These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19557470)

  • 1. [Premature ejaculation].
    Porst H
    Urologe A; 2009 Jun; 48(6):663-74. PubMed ID: 19557470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review.
    Porst H; Burri A
    Sex Med Rev; 2019 Jan; 7(1):129-140. PubMed ID: 30057136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
    Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
    J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of pharmacotherapy in premature ejaculation.
    Porst H
    J Sex Med; 2011 Oct; 8 Suppl 4():335-41. PubMed ID: 21967395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature ejaculation: treatment update.
    McCarty EJ; Dinsmore WW
    Int J STD AIDS; 2010 Feb; 21(2):77-81. PubMed ID: 20089991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on treatments for premature ejaculation.
    Hellstrom WJ
    Int J Clin Pract; 2011 Jan; 65(1):16-26. PubMed ID: 21155940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
    McMahon CG; Porst H
    J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Available and future therapies for premature ejaculation.
    Hellstrom WJ
    Drugs Today (Barc); 2010 Jul; 46(7):507-21. PubMed ID: 20683504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
    Waldinger MD; Schweitzer DH
    J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dapoxetine for premature ejaculation: Advances in clinical studies].
    Zhou TY; Li YF
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):931-6. PubMed ID: 26665685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapoxetine for premature ejaculation.
    McMahon CG
    Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
    Hutchinson K; Cruickshank K; Wylie K
    Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation.
    Cormio L; Massenio P; La Rocca R; Verze P; Mirone V; Carrieri G
    J Sex Med; 2015 Jul; 12(7):1609-15. PubMed ID: 26077706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.
    Althof SE; Brock GB; Rosen RC; Rowland DL; Aquilina JW; Rothman M; Tesfaye F; Bull S
    J Sex Med; 2010 Jun; 7(6):2243-2252. PubMed ID: 20367770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapoxetine: a novel treatment for premature ejaculation.
    Owen RT
    Drugs Today (Barc); 2009 Sep; 45(9):669-78. PubMed ID: 19956808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapoxetine for premature ejaculation.
    Feige AM; Pinsky MR; Hellstrom WJ
    Clin Pharmacol Ther; 2011 Jan; 89(1):125-8. PubMed ID: 21085116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.